Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|13|1888-1895

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.13, 2016-04, pp. : 1888-1895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI

By  

Current Pharmaceutical Design, Vol. 23, Iss. 9, 2017-04 ,pp. : 1328-1333

Bentham Science Publishers

Access to resources Recommend Favorite

Current Treatment Recommendations in Antiarrhythmic Therapy

By Van Gelder I.C.   Brügemann J.   Crijns H.J.G.M.  

Drugs, Vol. 55, Iss. 3, 1998-03 ,pp. : 331-346

Adis International

Access to resources Recommend Favorite

Antiplatelet Agents and Anticoagulants: From Pharmacology to Clinical Practice

By  

Current Pharmaceutical Design, Vol. 23, Iss. 9, 2017-04 ,pp. : 1279-1293

Bentham Science Publishers

Access to resources Recommend Favorite

Tailoring Antiplatelet Therapy: A Step Toward Individualized Therapy to Improve Clinical Outcome?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5392-5401

Bentham Science Publishers

Access to resources Recommend Favorite

Current Drug Therapy Recommendations for the Treatment of Endometriosis

By Bergqvist A.  

Drugs, Vol. 58, Iss. 1, 1999-07 ,pp. : 39-50

Adis International

Access to resources Recommend Favorite